Unmet needs in psoriatic arthritis patients receiving immunomodulatory therapy: results from a large multinational real-world study
2019
Objective
There are limited data on therapy selection and switching in psoriatic arthritis (PsA). This 18 country, real-world study assessed use and switching of immunomodulatory therapy (biologic/apremilast), the extent of treatment failure and its association with reduced physical functioning, health-related quality of life (HRQoL), and work productivity and activity impairment (WPAI).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
39
References
8
Citations
NaN
KQI